Keyword: Neupogen

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...


Novartis Can Sell Neupogen Copy in US in September

24.07.2015 - A US federal appeals court has ruled that Swiss drugmaker Novartis can begin selling Zarxio, its lower-cost generic version of an Amgen drug, on the US market starting in September...


FDA Approves the First-Ever US Biosimilar

16.03.2015 - The US Food & Drug Administration has approved the country's first biosimilar product, a move observers say will open the door for lower cost, generic-like biological drugs. The...